UK markets closed

Oxford BioMedica plc (OXB.L)

LSE - LSE Delayed price. Currency in GBp (0.01 GBP)
Add to watchlist
220.00+1.50 (+0.69%)
At close: 05:05PM BST
Show:
Income statement
Balance sheet
Annual

Cash flow

Currency in GBP. All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-61,630
-39,157
19,011
-6,245
Depreciation & amortisation
30,058
26,359
12,456
9,839
Stock-based compensation
6,801
6,471
3,981
3,289
Change in working capital
49,469
4,932
-12,909
-12,154
Inventory
303
688
-2,609
-4,333
Other working capital
-8,659
-28,911
15,994
-10,242
Other non-cash items
-12,380
-4,994
1,053
1,709
Net cash provided by operating activities
6,482
-12,615
25,455
3,116
Cash flows from investing activities
Investments in property, plant and equipment
-15,141
-16,296
-9,461
-13,358
Acquisitions, net
0
-99,206
0
-
Sales/maturities of investments
-
-
0
2,523
Other investing activities
-
-1,420
-
-
Net cash used for investing activities
50,451
-56,462
-9,461
-10,801
Net change in cash
12,087
29,545
62,201
30,500
Cash at beginning of period
118,510
108,944
46,743
16,243
Cash at end of period
130,597
141,285
108,944
46,743
Free cash flow
Operating cash flow
6,482
-12,615
25,455
3,116
Capital expenditure
-15,141
-16,296
-9,461
-13,358
Free cash flow
-8,659
-28,911
15,994
-10,242